Survivin promotes rheumatoid arthritis fibroblast‐like synoviocyte cell proliferation, and the expression of angiogenesis‐related proteins by activating the <scp>NOTCH</scp> pathway: Correspondence-Reference-Cited by-同舟云学术

Survivin promotes rheumatoid arthritis fibroblast‐like synoviocyte cell proliferation, and the expression of angiogenesis‐related proteins by activating the NOTCH pathway: Correspondence

Published:2022-12 Issue:5 Volume:26 Page:984-985
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J of Rheum Dis

Author:

Yeh Wen‐Bin¹^ORCID,Lee Wei‐Kai²³^ORCID,Chou Mei‐Chia⁴,Yong Su‐Boon⁵⁶^ORCID,Li Chia‐Jung⁷⁸^ORCID

Affiliation:

1. Department of Emergency Medicine Kaohsiung Municipal Min‐Sheng Hospital Kaohsiung Taiwan

2. Department of Emergency Medicine, Sinying Hospital Ministry of Health and Welfare Tainan Taiwan

3. Min‐Hwei Junior College of Health Care Management Tainan Taiwan

4. Department of Physical Medicine and Rehabilitation Pingtung Veterans General Hospital Pingtung Taiwan

5. Institute of Medicine Chung Shan Medical University Taichung Taiwan

6. Division of Pediatric Allergy, Immunology, Rheumatology Lin‐Shin Hospital Taichung Taiwan

7. Department of Obstetrics and Gynecology Kaohsiung Veterans General Hospital Kaohsiung Taiwan

8. Institute of BioPharmaceutical Sciences National Sun Yat‐sen University Kaohsiung Taiwan

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.14509

Reference3 articles.

1. Survivin promotes rheumatoid arthritis fibroblast‐like synoviocyte cell proliferation, and the expression of angiogenesis‐related proteins by activating the NOTCH pathway

2. Serum VEGF‐A and VEGFR‐1 levels in patients with adult immunoglobulin A vasculitis

3. VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging trends in clinical research on Janus kinase inhibitors for atopic dermatitis treatment;International Immunopharmacology;2023-11